ROCHE HOLDING AG-GENUSSCHEIN (1ROG.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1ROG - CH0012032048 - Common Stock
380 EUR
+38 (+11.11%)
Overall 1ROG gets a fundamental rating of 6 out of 10. We evaluated 1ROG against 55 industry peers in the Pharmaceuticals industry. 1ROG scores excellent on profitability, but there are some minor concerns on its financial health. 1ROG has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
1ROG had positive earnings in the past year.
1ROG had a positive operating cash flow in the past year.
Each year in the past 5 years 1ROG has been profitable.
1ROG had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 9.95%, 1ROG is in the better half of the industry, outperforming 70.91% of the companies in the same industry.
1ROG has a better Return On Equity (32.88%) than 83.64% of its industry peers.
Looking at the Return On Invested Capital, with a value of 24.24%, 1ROG belongs to the top of the industry, outperforming 90.91% of the companies in the same industry.
1ROG had an Average Return On Invested Capital over the past 3 years of 23.72%. This is significantly above the industry average of 13.65%.
The 3 year average ROIC (23.72%) for 1ROG is below the current ROIC(24.24%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.95% | ||
| ROE | 32.88% | ||
| ROIC | 24.24% |
ROA(3y)11.64%
ROA(5y)13.32%
ROE(3y)36.55%
ROE(5y)41.17%
ROIC(3y)23.72%
ROIC(5y)23.71%
1.3 Margins
With a Profit Margin value of 15.31%, 1ROG perfoms like the industry average, outperforming 58.18% of the companies in the same industry.
In the last couple of years the Profit Margin of 1ROG has declined.
Looking at the Operating Margin, with a value of 33.79%, 1ROG belongs to the top of the industry, outperforming 85.45% of the companies in the same industry.
1ROG's Operating Margin has been stable in the last couple of years.
Looking at the Gross Margin, with a value of 73.92%, 1ROG is in the better half of the industry, outperforming 65.45% of the companies in the same industry.
In the last couple of years the Gross Margin of 1ROG has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 33.79% | ||
| PM (TTM) | 15.31% | ||
| GM | 73.92% |
OM growth 3Y4.01%
OM growth 5Y0.18%
PM growth 3Y-14.88%
PM growth 5Y-9.03%
GM growth 3Y2.22%
GM growth 5Y0.6%
2. Health
2.1 Basic Checks
1ROG has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, 1ROG has less shares outstanding
Compared to 5 years ago, 1ROG has less shares outstanding
The debt/assets ratio for 1ROG is higher compared to a year ago.
2.2 Solvency
1ROG has an Altman-Z score of 4.71. This indicates that 1ROG is financially healthy and has little risk of bankruptcy at the moment.
1ROG has a Altman-Z score of 4.71. This is in the better half of the industry: 1ROG outperforms 67.27% of its industry peers.
The Debt to FCF ratio of 1ROG is 2.50, which is a good value as it means it would take 1ROG, 2.50 years of fcf income to pay off all of its debts.
1ROG has a better Debt to FCF ratio (2.50) than 69.09% of its industry peers.
1ROG has a Debt/Equity ratio of 1.06. This is a high value indicating a heavy dependency on external financing.
1ROG has a worse Debt to Equity ratio (1.06) than 65.45% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.06 | ||
| Debt/FCF | 2.5 | ||
| Altman-Z | 4.71 |
ROIC/WACC5.1
WACC4.75%
2.3 Liquidity
1ROG has a Current Ratio of 1.29. This is a normal value and indicates that 1ROG is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.29, 1ROG perfoms like the industry average, outperforming 45.45% of the companies in the same industry.
1ROG has a Quick Ratio of 1.02. This is a normal value and indicates that 1ROG is financially healthy and should not expect problems in meeting its short term obligations.
1ROG has a Quick ratio (1.02) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.29 | ||
| Quick Ratio | 1.02 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 5.19% over the past year.
The Earnings Per Share has been decreasing by -1.39% on average over the past years.
1ROG shows a small growth in Revenue. In the last year, the Revenue has grown by 4.77%.
Measured over the past years, 1ROG shows a decrease in Revenue. The Revenue has been decreasing by -0.32% on average per year.
EPS 1Y (TTM)5.19%
EPS 3Y-1.73%
EPS 5Y-1.39%
EPS Q2Q%8.5%
Revenue 1Y (TTM)4.77%
Revenue growth 3Y-1.24%
Revenue growth 5Y-0.32%
Sales Q2Q%3.67%
3.2 Future
The Earnings Per Share is expected to grow by 6.07% on average over the next years.
1ROG is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.19% yearly.
EPS Next Y5.56%
EPS Next 2Y5.15%
EPS Next 3Y5.5%
EPS Next 5Y6.07%
Revenue Next Year2.32%
Revenue Next 2Y2.54%
Revenue Next 3Y2.72%
Revenue Next 5Y3.19%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 17.99, the valuation of 1ROG can be described as rather expensive.
63.64% of the companies in the same industry are more expensive than 1ROG, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.00. 1ROG is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 17.02, 1ROG is valued on the expensive side.
The rest of the industry has a similar Price/Forward Earnings ratio as 1ROG.
1ROG is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.70, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.99 | ||
| Fwd PE | 17.02 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1ROG is on the same level as its industry peers.
1ROG's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.69 | ||
| EV/EBITDA | 12.63 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
1ROG has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)3.24
PEG (5Y)N/A
EPS Next 2Y5.15%
EPS Next 3Y5.5%
5. Dividend
5.1 Amount
1ROG has a Yearly Dividend Yield of 2.96%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 1.60, 1ROG pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 1.94, 1ROG pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.96% |
5.2 History
The dividend of 1ROG has a limited annual growth rate of 2.37%.
Dividend Growth(5Y)2.37%
Div Incr YearsN/A
Div Non Decr YearsN/A
5.3 Sustainability
85.87% of the earnings are spent on dividend by 1ROG. This is not a sustainable payout ratio.
1ROG's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP85.87%
EPS Next 2Y5.15%
EPS Next 3Y5.5%
BIT:1ROG (1/7/2026, 7:00:00 PM)
380
+38 (+11.11%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners40.79%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap307.51B
Revenue(TTM)61.59B
Net Income(TTM)9.43B
Analysts70.37
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.96% |
Yearly Dividend10.84
Dividend Growth(5Y)2.37%
DP85.87%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.01%
EPS NY rev (3m)-1.57%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.17%
Revenue NY rev (3m)-0.4%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.99 | ||
| Fwd PE | 17.02 | ||
| P/S | 4.65 | ||
| P/FCF | 21.69 | ||
| P/OCF | 14.85 | ||
| P/B | 9.99 | ||
| P/tB | 65.89 | ||
| EV/EBITDA | 12.63 |
EPS(TTM)21.12
EY5.56%
EPS(NY)22.32
Fwd EY5.87%
FCF(TTM)17.52
FCFY4.61%
OCF(TTM)25.58
OCFY6.73%
SpS81.73
BVpS38.06
TBVpS5.77
PEG (NY)3.24
PEG (5Y)N/A
Graham Number134.48
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.95% | ||
| ROE | 32.88% | ||
| ROCE | 30.98% | ||
| ROIC | 24.24% | ||
| ROICexc | 25.87% | ||
| ROICexgc | 40.74% | ||
| OM | 33.79% | ||
| PM (TTM) | 15.31% | ||
| GM | 73.92% | ||
| FCFM | 21.43% |
ROA(3y)11.64%
ROA(5y)13.32%
ROE(3y)36.55%
ROE(5y)41.17%
ROIC(3y)23.72%
ROIC(5y)23.71%
ROICexc(3y)28.94%
ROICexc(5y)29.11%
ROICexgc(3y)49.53%
ROICexgc(5y)49.86%
ROCE(3y)29.26%
ROCE(5y)30.68%
ROICexgc growth 3Y2.54%
ROICexgc growth 5Y-3.21%
ROICexc growth 3Y1.27%
ROICexc growth 5Y-3.5%
OM growth 3Y4.01%
OM growth 5Y0.18%
PM growth 3Y-14.88%
PM growth 5Y-9.03%
GM growth 3Y2.22%
GM growth 5Y0.6%
F-Score8
Asset Turnover0.65
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.06 | ||
| Debt/FCF | 2.5 | ||
| Debt/EBITDA | 1.25 | ||
| Cap/Depr | 175.31% | ||
| Cap/Sales | 9.87% | ||
| Interest Coverage | 17.17 | ||
| Cash Conversion | 79.41% | ||
| Profit Quality | 140.01% | ||
| Current Ratio | 1.29 | ||
| Quick Ratio | 1.02 | ||
| Altman-Z | 4.71 |
F-Score8
WACC4.75%
ROIC/WACC5.1
Cap/Depr(3y)132.99%
Cap/Depr(5y)129.62%
Cap/Sales(3y)7.8%
Cap/Sales(5y)8.42%
Profit Quality(3y)129.49%
Profit Quality(5y)117.9%
High Growth Momentum
Growth
EPS 1Y (TTM)5.19%
EPS 3Y-1.73%
EPS 5Y-1.39%
EPS Q2Q%8.5%
EPS Next Y5.56%
EPS Next 2Y5.15%
EPS Next 3Y5.5%
EPS Next 5Y6.07%
Revenue 1Y (TTM)4.77%
Revenue growth 3Y-1.24%
Revenue growth 5Y-0.32%
Sales Q2Q%3.67%
Revenue Next Year2.32%
Revenue Next 2Y2.54%
Revenue Next 3Y2.72%
Revenue Next 5Y3.19%
EBIT growth 1Y10.03%
EBIT growth 3Y2.72%
EBIT growth 5Y-0.14%
EBIT Next Year23.19%
EBIT Next 3Y10.25%
EBIT Next 5Y8.74%
FCF growth 1Y12.91%
FCF growth 3Y-2.8%
FCF growth 5Y-2.91%
OCF growth 1Y19.07%
OCF growth 3Y-1.42%
OCF growth 5Y-2.14%
ROCHE HOLDING AG-GENUSSCHEIN / 1ROG.MI FAQ
Can you provide the ChartMill fundamental rating for ROCHE HOLDING AG-GENUSSCHEIN?
ChartMill assigns a fundamental rating of 6 / 10 to 1ROG.MI.
What is the valuation status for 1ROG stock?
ChartMill assigns a valuation rating of 4 / 10 to ROCHE HOLDING AG-GENUSSCHEIN (1ROG.MI). This can be considered as Fairly Valued.
Can you provide the profitability details for ROCHE HOLDING AG-GENUSSCHEIN?
ROCHE HOLDING AG-GENUSSCHEIN (1ROG.MI) has a profitability rating of 8 / 10.
What is the valuation of ROCHE HOLDING AG-GENUSSCHEIN based on its PE and PB ratios?
The Price/Earnings (PE) ratio for ROCHE HOLDING AG-GENUSSCHEIN (1ROG.MI) is 17.99 and the Price/Book (PB) ratio is 9.99.
What is the expected EPS growth for ROCHE HOLDING AG-GENUSSCHEIN (1ROG.MI) stock?
The Earnings per Share (EPS) of ROCHE HOLDING AG-GENUSSCHEIN (1ROG.MI) is expected to grow by 5.56% in the next year.